Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-072279·DiaMedica Therapeutics Inc.
Schedule 13G ownership disclosure
DiaMedica Therapeutics Inc
Common Shares, no par value · CUSIP: 25253X207
Event date: 2025-07-23
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Trill AB
Shares: 6,764,465.00 · Class: 13.14%
- Jan Stahlberg
Shares: 6,764,465.00 · Class: 13.14%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-072279
- Form type
- SCHEDULE 13G/A
- Filer
- DiaMedica Therapeutics Inc.
- CIK
- CIK 1401040
- Filed
- Jul 30, 2025
- Reporting period
- Jul 23, 2025
- Description
- Schedule 13G beneficial ownership